Fig. 6From: Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patientsBar plots showing the glutamate content in glial cells in comparison to cell viability for different doses of memantine, parbendazole and bortezomib, after drug treatment on Day 1 and Day 2. A significant change in the ratio compared to the control is indicated by the * signBack to article page